Anebulo Pharmaceuticals, Inc.

Q4-CY2025

Q3-CY2025

Q2-CY2025

Q1-CY2025

Q4-CY2024

Q3-CY2024

Q2-CY2024

Q1-CY2024

Q4-CY2023

Q3-CY2023

Q2-CY2023

Q1-CY2023

Q4-CY2022

Q3-CY2022

Q2-CY2022

Q1-CY2022

Q4-CY2021

Q3-CY2021

Q2-CY2021

Q1-CY2021

Q4-CY2020

Q3-CY2020

Q2-CY2020

Q1-CY2020

Q4-CY2019

Q3-CY2019

Q2-CY2019

Q1-CY2019

Q4-CY2018

Q3-CY2018

Q2-CY2018

Q1-CY2018

Q4-CY2017

Q3-CY2017

Q2-CY2017

Q1-CY2017

Q4-CY2016

Q3-CY2016

Q2-CY2016

Q1-CY2016

Q4-CY2015

Q3-CY2015

Q2-CY2015

Q1-CY2015

Q4-CY2014

Q3-CY2014

Q2-CY2014

Q1-CY2014

Q4-CY2013

Balance Sheet Date

2025-Jun-30

2025-Mar-31

2024-Dec-31

2024-Sep-30

2024-Jun-30

2024-Mar-31

2023-Dec-31

2023-Sep-30

2023-Jun-30

2023-Mar-31

2022-Dec-31

2022-Sep-30

2022-Jun-30

2022-Mar-31

2021-Dec-31

2021-Sep-30

2021-Mar-31

Fiscal Period

Q4-FY2025

Q3-FY2025

Q2-FY2025

Q1-FY2025

Q4-FY2024

Q3-FY2024

Q2-FY2024

Q1-FY2024

Q4-FY2023

Q3-FY2023

Q2-FY2023

Q1-FY2023

Q4-FY2022

Q3-FY2022

Q2-FY2022

Q1-FY2021

Q3-FY2020

Close Price of Common Stock

2.29$

2.37$

1.48$

1.35$

1.72$

1.92$

2.68$

2.91$

2.54$

3.19$

2.48$

2.88$

2.43$

3.11$

4.72$

6.01$

6.31$

7.01$

Market Cap of Common Stock

94,084,034$

97,370,812$

60,805,402$

55,464,387$

44,605,133$

49,791,777$

69,501,022$

75,465,661$

65,108,371$

81,769,962$

63,570,378$

73,823,665$

62,288,717$

72,676,243$

110,186,356$

140,300,848$

147,304,218$

163,645,415$

Close Price of Warrant

Close Price of Unit

Close Price of Right

• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation